Published in Eur J Cancer on June 01, 2001
Electrochemotherapy: from the drawing board into medical practice. Biomed Eng Online (2014) 1.25
Potentiation of electrochemotherapy by intramuscular IL-12 gene electrotransfer in murine sarcoma and carcinoma with different immunogenicity. Radiol Oncol (2012) 0.94
Antitumor efficiency of electrochemotherapy by high and low frequencies and repetitive therapy in the treatment of invasive ductal carcinoma in BALB/c mice. Cell J (2012) 0.79
In Vitro and in vivo Evaluation of Electrochemotherapy with trans-platinum Analogue trans-[PtCl2(3-Hmpy)2]. Radiol Oncol (2017) 0.75
Centriole disassembly in vivo and its effect on centrosome structure and function in vertebrate cells. J Cell Biol (1998) 2.92
Electrochemotherapy potentiation of antitumour effect of bleomycin by local electric pulses. Eur J Cancer (1991) 2.79
Electrochemotherapy in treatment of tumours. Eur J Surg Oncol (2007) 2.51
Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy. Br J Cancer (1998) 2.11
Transient electropermeabilization of cells in culture. Increase of the cytotoxicity of anticancer drugs. Biochem Pharmacol (1988) 1.91
Electrochemotherapy, a new antitumor treatment. First clinical phase I-II trial. Cancer (1993) 1.90
Antitumor effectiveness of electrochemotherapy with cis-diamminedichloroplatinum(II) in mice. Cancer Res (1995) 1.85
A validated model of in vivo electric field distribution in tissues for electrochemotherapy and for DNA electrotransfer for gene therapy. Biochim Biophys Acta (2000) 1.83
Bleomycin, an apoptosis-mimetic drug that induces two types of cell death depending on the number of molecules internalized. Cancer Res (1993) 1.74
The importance of electric field distribution for effective in vivo electroporation of tissues. Biophys J (1998) 1.61
Cell electropermeabilization: a new tool for biochemical and pharmacological studies. Biochim Biophys Acta (1993) 1.61
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
Analytical description of transmembrane voltage induced by electric fields on spheroidal cells. Biophys J (2000) 1.59
Antitumor effectiveness of electrochemotherapy: a systematic review and meta-analysis. Eur J Surg Oncol (2012) 1.55
Heated intra-operative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis: pharmacokinetics and tissue distribution. Ann Oncol (2002) 1.55
Vascular disrupting action of electroporation and electrochemotherapy with bleomycin in murine sarcoma. Br J Cancer (2008) 1.53
[Electrochemotherapy, a new antitumor treatment: first clinical trial]. C R Acad Sci III (1991) 1.52
Electrochemotherapy: a new technological approach in treatment of metastases in the liver. Technol Cancer Res Treat (2011) 1.50
Electropermeabilization of cells in tissues assessed by the qualitative and quantitative electroloading of bleomycin. Biochim Biophys Acta (1994) 1.42
Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41
Phase I/II trial for the treatment of cutaneous and subcutaneous tumors using electrochemotherapy. Cancer (1996) 1.41
Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7 TeV. Phys Rev Lett (2011) 1.39
Efficiency of high- and low-voltage pulse combinations for gene electrotransfer in muscle, liver, tumor, and skin. Hum Gene Ther (2008) 1.39
DNA electrotransfer: its principles and an updated review of its therapeutic applications. Gene Ther (2004) 1.37
Very high cytotoxicity of bleomycin introduced into the cytosol of cells in culture. Biochem Pharmacol (1991) 1.37
Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34
Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32
Electrically-assisted nucleic acids delivery to tissues in vivo: where do we stand? Curr Pharm Des (2006) 1.31
Treatment of muscle injuries by local administration of autologous conditioned serum: a pilot study on sportsmen with muscle strains. Int J Sports Med (2004) 1.31
Enhancement of cytotoxicity by electropermeabilization: an improved method for screening drugs. Anticancer Drugs (1998) 1.30
Antitumor electrochemotherapy: new advances in the clinical protocol. Cancer (1996) 1.30
Observation of associated near-side and away-side long-range correlations in sqrt[s(NN)]=5.02 TeV proton-lead collisions with the ATLAS detector. Phys Rev Lett (2013) 1.27
An assay for dopamine-beta-hydroxylase activity in tissues and serum. Experientia (1971) 1.26
Electrochemotherapy of spontaneous mammary tumours in mice. Eur J Cancer (1991) 1.26
In vivo electroporation of skeletal muscle: threshold, efficacy and relation to electric field distribution. Biochim Biophys Acta (1999) 1.24
Search for dark matter candidates and large extra dimensions in events with a photon and missing transverse momentum in pp collision data at sqrt[s]=7 TeV with the ATLAS detector. Phys Rev Lett (2013) 1.19
Impact of monitoring plasma 1,1-dichlorodiphenildichloroethane (o,p'DDD) levels on the treatment of patients with adrenocortical carcinoma. Cancer (2001) 1.19
Electrochemotherapy with cisplatin: clinical experience in malignant melanoma patients. Clin Cancer Res (2000) 1.19
Evolution of cell-mediated antitumor immunity in mice bearing a syngeneic chemically induced tumor. Influence of tumor growth, surgical removal and treatment with irradiated tumor cells. Int J Cancer (1972) 1.17
Prognostic factors in the prediction of chronic wound healing by electrical stimulation. Med Biol Eng Comput (2001) 1.15
Electrochemotherapy tumor treatment is improved by interleukin-2 stimulation of the host's defenses. Eur Cytokine Netw (1992) 1.15
Search for a supersymmetric partner to the top quark in final states with jets and missing transverse momentum at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.13
Increasing the repetition frequency of electric pulse delivery reduces unpleasant sensations that occur in electrochemotherapy. Neoplasma (2007) 1.12
The effect of pulse repetition frequency on the uptake into electropermeabilized cells in vitro with possible applications in electrochemotherapy. Bioelectrochemistry (2002) 1.11
Tumor blood flow modifying effect of electrochemotherapy with bleomycin. Anticancer Res (2000) 1.11
Internalisation of the bleomycin molecules responsible for bleomycin toxicity: a receptor-mediated endocytosis mechanism. Biochem Pharmacol (1999) 1.10
Systemic antitumor effects of electrochemotherapy combined with histoincompatible cells secreting interleukin-2. J Immunother Emphasis Tumor Immunol (1995) 1.10
Electrochemotherapy with cisplatin: potentiation of local cisplatin antitumour effectiveness by application of electric pulses in cancer patients. Eur J Cancer (1998) 1.10
Effects of steroids and verapamil on P-glycoprotein ATPase activity: progesterone, desoxycorticosterone, corticosterone and verapamil are mutually non-exclusive modulators. Biochem J (1996) 1.10
Treatment of muscle injuries by local administration of autologous conditioned serum: animal experiments using a muscle contusion model. Int J Sports Med (2004) 1.09
A new brain tumour therapy combining bleomycin with in vivo electropermeabilization. Biochem Biophys Res Commun (1993) 1.09
Importance of association between permeabilization and electrophoretic forces for intramuscular DNA electrotransfer. Biochim Biophys Acta (2000) 1.08
Search for tb resonances in proton-proton collisions at √s=7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.07
The ratio of single- to double-strand DNA breaks and their absolute values determine cell death pathway. Br J Cancer (2001) 1.06
Increased platinum accumulation in SA-1 tumour cells after in vivo electrochemotherapy with cisplatin. Br J Cancer (1999) 1.05
Competitive and non-competitive inhibition of the multidrug-resistance-associated P-glycoprotein ATPase--further experimental evidence for a multisite model. Eur J Biochem (1997) 1.05
Numerical determination of transmembrane voltage induced on irregularly shaped cells. Ann Biomed Eng (2006) 1.05
Search for a light Higgs boson decaying to long-lived weakly interacting particles in proton-proton collisions at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.05
Identification of a plasma membrane protein that specifically binds bleomycin. Biochem Biophys Res Commun (1993) 1.04
Role of pulse shape in cell membrane electropermeabilization. Biochim Biophys Acta (2003) 1.04
Pathophysiology and therapy of irinotecan-induced delayed-onset diarrhea in patients with advanced colorectal cancer: a prospective assessment. J Clin Oncol (1998) 1.03
Electroporation of human microvascular endothelial cells: evidence for an anti-vascular mechanism of electrochemotherapy. Br J Cancer (2001) 1.03
Relationships between DNA fragmentation, chromatin condensation, and changes in flow cytometry profiles detected during apoptosis. Exp Cell Res (1995) 1.03
Cell membrane electropermeabilization by symmetrical bipolar rectangular pulses. Part I. Increased efficiency of permeabilization. Bioelectrochemistry (2001) 1.01
A study of the immunological response to tumor ablation with irreversible electroporation. Technol Cancer Res Treat (2007) 1.01
Comparison of antibody, antigen, and metabolite assays for hospitalized patients with disseminated or peripheral candidiasis. J Clin Microbiol (1990) 1.01
Optimization of a gene electrotransfer method for mesenchymal stem cell transfection. Gene Ther (2008) 1.00
Electrochemotherapy in veterinary oncology. J Vet Intern Med (2008) 0.99
Search for supersymmetry in events with three leptons and missing transverse momentum in √[s]=7 TeV pp collisions with the ATLAS detector. Phys Rev Lett (2012) 0.99
Electrochemotherapy on liver tumours in rabbits. Br J Cancer (1998) 0.99
The influence of medium conductivity on electropermeabilization and survival of cells in vitro. Bioelectrochemistry (2001) 0.98
Determination of optimal parameters for in vivo gene transfer by electroporation, using a rapid in vivo test for cell permeabilization. Biochem Biophys Res Commun (1999) 0.98
Determination of the lipid bilayer breakdown voltage by means of linear rising signal. Bioelectrochemistry (2006) 0.97
Involvement of membrane bleomycin-binding sites in bleomycin cytotoxicity. Biochem Pharmacol (1994) 0.96
Parameters of postocclusive reactive hyperemia measured by near infrared spectroscopy in patients with peripheral vascular disease and in healthy volunteers. Ann Biomed Eng (2001) 0.96
Search for the rare leptonic decay B--->tau-nutau. Phys Rev Lett (2005) 0.96